Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury

NCT01484184 is registered in ClinicalTrials.gov with Nordic Life Science Pipeline Inc. as lead sponsor.

NCT NCT01484184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01484184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury
Lead sponsor
Nordic Life Science Pipeline Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury